Cangrelor compared with clopidogrel in patients with prior myocardial infarction – Insights from the CHAMPION trials
Author:
Funder
The Medicines Company
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference29 articles.
1. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective;Jernberg;Eur. Heart J.,2015
2. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial;Scirica;Lancet,2012
3. Long-term use of ticagrelor in patients with prior myocardial infarction;Bonaca;N. Engl. J. Med.,2015
4. Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction;Yeh;J. Am. Coll. Cardiol.,2015
5. Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry;van Werkum;J. Am. Coll. Cardiol.,2009
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Temporal Trends and Outcome of Patients with Acute Coronary Syndrome and Prior Myocardial Infarction;Journal of Clinical Medicine;2021-11-27
2. Efficacy and Safety of Long‐Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta‐analysis of Randomized Controlled Trials;Journal of the American Heart Association;2021-03-16
3. Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis;Scientific Reports;2020-10-08
4. Monitoring and tailoring the P2Y12 ADP receptor blocker therapy;Vnitřní lékařství;2020-02-21
5. Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use;Therapeutic Advances in Cardiovascular Disease;2019-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3